you have Type 2 Diabetes and are concerned about the health of your heart, this study could be for you.
Those with diabetes know they are at a higher risk of having heart attacks, strokes, and other cardiovascular complications. If you've already had a stroke or a heart attack your chances are doubled for having another one. This study is seeking people who have type 2 diabetes to evaluate the effect of a new GLP-1 treatment, Efpeglenatide (similar to Victoza, Byetta, Trulicity, etc.). Efpeglenatide has been tested previously in approximately 720 humans and the results have shown a positive effect on glucose in the blood.
This study is approximately three years long. All study visits are conducted locally in Salt Lake City, Utah.